Skip to main content
. 2017 Apr 12;8(29):48424–48435. doi: 10.18632/oncotarget.17053

Table 4. LncRNAs potentially serve as therapeutic targets for RCC.

LncRNAs Location Properties/Mechanisms References
HOTAIR chromosome 12 recruit and bind on the locus of EZH2 and H3K27me3 80
inhibit cycle-related genes p53, p21 and p16 80
modulate covalent histones 80
interact with methyltransferase PRC2, histone demethylase LSD1 80
regulates gene silencing 80
required for H3K27 trimethylation 81
transcriptional silencing across the HOXD locus 81
RCCRT1 chr5:137801181-137805004 upregulated in RCC 49
upregulated predicts poor survival of RCC 49
MALAT1 chromosome 11q13 independent predictor of OS in ccRCC 50, 51
sequester serine/arginine splicing factors in nuclear speckle domains 83, 84
regulate alternative splicing 84
transcriptional activation of MALAT1 by c-Fos contribute to oncogenesis 51
interact with Ezh2 51
reciprocally repressed with miR205 51
regulate EMT via E-cadherin and β-catenin 51
promote ZEB2 expression by sponging miR-200s 85
H19 11p15.5 exon 1 of H19 harbors a miRNA-containing hairpin 86
serve as the template of two miR6755p and miR6753p 86
LncRNA-SRLR 3q24 upregulated in intrinsically sorafenib resistant RCC 87
LncARSR 9q82.120.717-82.185.824 promote sunitinib resistance of RCC 88
competitively bind to miR-34/miR-449 88
facilitate AXL and c-MET expression 88
exosome-transferred lncARSR confer sunitinib resistance 88
targeting lncARSR restores sunitinib response in RCC 88
CADM1-AS1 antisense direction of a coding exon ofthe cell adhesion molecule 1 (CADM1) involved in renal carcinogenesisindependent prognostic factor for ccRCC 60
60